Human Immunodeficiency Virus (HIV) is a viral infection that attacks the immune system, leaving individuals susceptible to infections and illnesses that can lead to Acquired Immunodeficiency Syndrome (AIDS). HIV/AIDS can cause various symptoms such as chronic pain, nausea, loss of appetite, and neuropathy. Medical cannabis has been proposed as a treatment option for patients experiencing these symptoms.

Several studies have shown that medical marijuana can be an effective treatment for various symptoms in HIV/AIDS patients. For example, a 2021 study published in the Journal of Acquired Immune Deficiency Syndromes found that medicinal cannabis use was associated with reduced neuropathic pain, improved appetite, and reduced opioid use in patients. Another study published in the Journal of Pain and Symptom Management in 2020 found that medicinal marijuana use was associated with reduced pain and improved sleep in HIV/AIDS patients.

Medical cannabis has also been found to be well-tolerated in patients, with few negative side effects. In a 2021 study published in the journal AIDS and Behavior, medicinal cannabis use was found to be associated with improved quality of life and reduced depressive symptoms in HIV/AIDS patients.

Overall, these studies suggest that medical marijuana can be an effective treatment option for various symptoms in HIV/AIDS patients, and is well-tolerated with minimal side effects. However, it is important to note that medical cannabis should not be used as a substitute for antiretroviral therapy (ART).

If you or someone you know is interested in starting the process to receive your medical cannabis card for symptom relief, please consult with a physician.